派博傳思國(guó)際中心

標(biāo)題: Titlebook: New Data and Updates for I-VII, III-V and II-VI Compounds; Volume 44, Subvolume U. R?ssler Book 20111st edition Springer-Verlag Berlin Heid [打印本頁(yè)]

作者: 交叉路口    時(shí)間: 2025-3-21 16:20
書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds影響因子(影響力)




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds影響因子(影響力)學(xué)科排名




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds被引頻次




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds被引頻次學(xué)科排名




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds年度引用




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds年度引用學(xué)科排名




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds讀者反饋




書(shū)目名稱New Data and Updates for I-VII, III-V and II-VI Compounds讀者反饋學(xué)科排名





作者: ORBIT    時(shí)間: 2025-3-21 20:26

作者: 智力高    時(shí)間: 2025-3-22 02:16
tients as therapeutic substances in itself already justifies at least some legal control. The human origin of these substances and their natural scarcity are further reasons for interference by society and the legislator.
作者: Projection    時(shí)間: 2025-3-22 06:21
tients as therapeutic substances in itself already justifies at least some legal control. The human origin of these substances and their natural scarcity are further reasons for interference by society and the legislator.
作者: ascetic    時(shí)間: 2025-3-22 09:16
t into what actually happens during disciplinary moments that ultimately leads to the disproportional tracking of particular students into exclusionary school disciplinary consequences, which funnels an undercl978-94-6209-449-9Series ISSN 2214-9864 Series E-ISSN 2214-9872
作者: intrude    時(shí)間: 2025-3-22 14:43

作者: 我要威脅    時(shí)間: 2025-3-22 17:24

作者: 消極詞匯    時(shí)間: 2025-3-22 23:16

作者: 擴(kuò)音器    時(shí)間: 2025-3-23 02:45
a and hyperchloremia. Further research is warranted to determine the optimal agent and their best means of administration (boluses vs. continuous infusions) for each neurocritical condition. More extensive clinical trials are needed to address long-term outcomes, adverse events, and quality of life with both agents.
作者: mediocrity    時(shí)間: 2025-3-23 08:38
view on balanced intravenous solutions, firstly, by providing a physiological background of balanced solutions; secondly, by summarizing their potential pathophysiologic effects; and lastly, by presenting the clinical evidence available at the present time to support or refute their use in specific neurosurgical scenarios.
作者: LUMEN    時(shí)間: 2025-3-23 13:25
offluid administration for all neurologic patients including, pediatric and geriatric. The proposed book will be useful for trainees and clinicians in any field of clinical neurosciences. It would be very usefu978-981-19-0956-6978-981-19-0954-2
作者: diabetes    時(shí)間: 2025-3-23 14:28

作者: inconceivable    時(shí)間: 2025-3-23 20:55

作者: 藕床生厭倦    時(shí)間: 2025-3-24 01:41

作者: 雪上輕舟飛過(guò)    時(shí)間: 2025-3-24 05:58
AgBr: phonon dispersion, phonon density of states,
作者: 核心    時(shí)間: 2025-3-24 10:01
AgBr: heat of fusion, molar heat capacity, thermodynamic functions,
作者: 壓艙物    時(shí)間: 2025-3-24 12:09
AgBrxI1-x: ionic conductivity, dielectric permittivity,
作者: FLORA    時(shí)間: 2025-3-24 16:13
AgCl: band structure, density of states, band gap,
作者: Silent-Ischemia    時(shí)間: 2025-3-24 22:34

作者: Offset    時(shí)間: 2025-3-25 00:58

作者: ureter    時(shí)間: 2025-3-25 04:13

作者: corn732    時(shí)間: 2025-3-25 07:42

作者: 脆弱吧    時(shí)間: 2025-3-25 14:49

作者: 美色花錢(qián)    時(shí)間: 2025-3-25 18:00

作者: Outspoken    時(shí)間: 2025-3-25 21:05
everal strategies for change management. An organisation needs to choose that strategy that best fits the requirements of a customer orientation. Commitment to the change process of every stakeholder within the system is essential. Constant monitoring of the effectiveness of improvements is of vital importance.
作者: 儀式    時(shí)間: 2025-3-26 02:12

作者: CUR    時(shí)間: 2025-3-26 04:56
ough the process of discerning, interpreting, and transformi“Revolution, not reform, is required to release the power of teaching …. Virtually, all teachers possess tremendous power which can be released, given the proper exposure. We can’t get to that point by tinkering with a broken system. We mus
作者: PANG    時(shí)間: 2025-3-26 08:54

作者: LURE    時(shí)間: 2025-3-26 13:58
options are provided for improved or new fast algorithms, s. . . that is what learning is. You suddenly understand something you‘ve un- derstood all your life, but in a new way. Various transforms have been widely used in diverse applications of science, engineering and technology. New transforms a
作者: gustation    時(shí)間: 2025-3-26 19:25

作者: Limerick    時(shí)間: 2025-3-26 21:54

作者: Emmenagogue    時(shí)間: 2025-3-27 02:27
-life situation to emulate the clinical diagnosis & managemeThis thoroughly revised and updated case-based book describes a variety of clinical scenarios in transfusion medicine?likely to be encountered in a busy teaching hospital. It highlights the stream of clinical and laboratory data available t
作者: Obstacle    時(shí)間: 2025-3-27 08:44
king and became now a medical discipline, with own theoretical and practical fundaments. Recently, M.A. Blajchman described this new discipline [.]: “Transfusion medicine is that multidisciplinary branch of medicine that focuses on all the available medical, scientific, and technical information app
作者: Blood-Vessels    時(shí)間: 2025-3-27 12:19

作者: 孤獨(dú)無(wú)助    時(shí)間: 2025-3-27 13:35

作者: 周興旺    時(shí)間: 2025-3-27 18:52
ere is so much at stake for society and its members if that system does not function properly, that there is no society that does not want to exert power over its health care system. In a democratic society the law is an appropriate instrument to establish such control. Has the law a particular role




歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
浮山县| 冀州市| 神农架林区| 西昌市| 镇远县| 崇文区| 齐齐哈尔市| 阿尔山市| 汕头市| 盐津县| 永川市| 长顺县| 佳木斯市| 嘉禾县| 南昌县| 巴彦淖尔市| 阜宁县| 云和县| 河津市| 申扎县| 博罗县| 尤溪县| 神池县| 武汉市| 通辽市| 阿拉尔市| 黑龙江省| 陇西县| 嵊州市| 周至县| 丽水市| 瑞金市| 临潭县| 万年县| 舟曲县| 夏河县| 临夏市| 庆城县| 泸西县| 临夏市| 阳东县|